KOVAI MEDICAL share price has zoomed 6% and is presently trading at Rs 5,260.7.
Meanwhile, the BSE HEALTHCARE index is at 42,991.0 (down 1.0%).
Among the top gainers in the BSE HEALTHCARE index today are CAPLIN POINT (up 2.5%) and MAX HEALTHCARE INSTITUTE (up 2.1%).
Glenmark Pharma (down 3.4%) and Dr. Reddys (down 3.4%) are among the top losers today.
Over the last one year, KOVAI MEDICAL has moved up from Rs 2,577.2 to Rs 5,260.7, registering a gain of Rs 2,683.5 (up 104.1%).
On the other hand, the BSE HEALTHCARE index has moved up from 27,318.2 to 42,991.0, registering a gain of 57.4% during the last 12 months.
The top gainers among the BSE HEALTHCARE index stocks during this same period were Jubilant Pharmova (up 227.5%), Glenmark Pharma (up 120.4%) and SUVEN PHARMACEUTICALS (up 118.7%).
Dear Reader: If You Invest in Midcap Stocks, this is for You
The BSE Sensex is at 79,871.9 (down 0.2%).
The top losers among the BSE Sensex today are Tata Motors (down 3.8%) and Maruti Suzuki (down 2.3%). The most traded stocks in the BSE Sensex are Tata Motors and Tata Steel.
In the meantime, NSE Nifty is at 24,287.7 (down 0.2%). Tata Motors and IOC are among the top losers in NSE NIFTY.
Over the last 12 months, the BSE Sensex has moved up from 64,049.1 to 79,871.9, registering a gain of 15,822.8 points (up 24.7%).
KOVAI MEDICAL net profit grew 47.4% YoY to Rs 458 million for the quarter ended June 2024, compared to a profit of Rs 311 million a year ago. Net sales rose 14.7% to Rs 3,151 million during the period as against Rs 2,746 million in April-June 2023.
For the year ended March 2024, KOVAI MEDICAL reported 55.3% increase in net profit to Rs 1,797 million compared to net profit of Rs 1,158 million during FY23. Revenue of the company grew 19.6% to Rs 12,196 million during FY24.
The current Price to earnings ratio of KOVAI MEDICAL, based on rolling 12 month earnings, stands at 29.6.
Equitymaster requests your view! Post a comment on "KOVAI MEDICAL Gains 6%; BSE HEALTHCARE Index Down 1.0%". Click here!
Comments are moderated by Equitymaster, in accordance with the Terms of Use, and may not appear
on this article until they have been reviewed and deemed appropriate for posting.
In the meantime, you may want to share this article with your friends!